Page last updated: 2024-11-04

tegafur and Angina Pectoris, Variant

tegafur has been researched along with Angina Pectoris, Variant in 2 studies

Angina Pectoris, Variant: A clinical syndrome characterized by the development of CHEST PAIN at rest with concomitant transient ST segment elevation in the ELECTROCARDIOGRAM, but with preserved exercise capacity.

Research Excerpts

ExcerptRelevanceReference
"A 58-year-old male with advanced gastric cancer underwent a total gastrectomy after neoadjuvant chemotherapy with paclitaxel and cisplatin."1.34A case of suspected vasospastic angina related to S-1 administration. ( Hoshi, Y; Kameda, K; Munakata, M; Muto, O; Sakata, Y; Shitara, K, 2007)

Research

Studies (2)

TimeframeStudies, this research(%)All Research%
pre-19901 (50.00)18.7374
1990's0 (0.00)18.2507
2000's1 (50.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Shitara, K1
Kameda, K1
Hoshi, Y1
Munakata, M1
Muto, O1
Sakata, Y1
Nakagawa, Y1
Ogawa, N1
Suzuki, H1
Miki, H1
Tominaga, M1
Takahashi, M1

Other Studies

2 other studies available for tegafur and Angina Pectoris, Variant

ArticleYear
A case of suspected vasospastic angina related to S-1 administration.
    Gan to kagaku ryoho. Cancer & chemotherapy, 2007, Volume: 34, Issue:10

    Topics: Angina Pectoris, Variant; Antimetabolites, Antineoplastic; Chemotherapy, Adjuvant; Coronary Vasospas

2007
[A case of variant angina induced by 5-fluorouracil and Tegafur].
    Kokyu to junkan. Respiration & circulation, 1988, Volume: 36, Issue:11

    Topics: Adenocarcinoma; Angina Pectoris, Variant; Coronary Vasospasm; Electrocardiography; Fluorouracil; Hum

1988